These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 14528099

  • 21. Role of high-dose chemotherapy with hematopoietic stem cell rescue in the treatment of metastatic or recurrent rhabdomyosarcoma.
    Weigel BJ, Breitfeld PP, Hawkins D, Crist WM, Baker KS.
    J Pediatr Hematol Oncol; 2001; 23(5):272-6. PubMed ID: 11464981
    [Abstract] [Full Text] [Related]

  • 22. Questionable role of CNS radioprophylaxis in the therapeutic management of childhood rhabdomyosarcoma with meningeal extension.
    Gasparini M, Lombardi F, Gianni MC, Massimino M, Gandola L, Fossati-Bellani F.
    J Clin Oncol; 1990 Nov; 8(11):1854-7. PubMed ID: 2230872
    [Abstract] [Full Text] [Related]

  • 23. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL, Anderson JR, Crist WM, Breneman JC, Wharam MD, Wiener ES, Qualman SJ, Donaldson SS.
    J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
    [Abstract] [Full Text] [Related]

  • 24. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS.
    Cancer; 2006 Apr 15; 106(8):1846-56. PubMed ID: 16541446
    [Abstract] [Full Text] [Related]

  • 25. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.
    Heyn R, Khan F, Ensign LG, Donaldson SS, Ruymann F, Smith MA, Vietti T, Maurer HM.
    Med Pediatr Oncol; 1994 Apr 15; 23(2):99-106. PubMed ID: 8202048
    [Abstract] [Full Text] [Related]

  • 26. Adherence to Treatment, Response and Patterns of Failure in Pediatric Parameningeal Rhabdomyosarcoma: Experience From a Tertiary Cancer Care Center From India.
    Roy S, Pathy S, Mohanti BK, Chander S, Biswas A.
    J Pediatr Hematol Oncol; 2017 Mar 15; 39(2):e62-e68. PubMed ID: 28060113
    [Abstract] [Full Text] [Related]

  • 27. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
    Raney B, Anderson J, Breneman J, Donaldson SS, Huh W, Maurer H, Michalski J, Qualman S, Ullrich F, Wharam M, Meyer W, Soft-Tissue Sarcoma Committee of the Children's Oncology Group, Arcadia, California, USA.
    Pediatr Blood Cancer; 2008 Jul 15; 51(1):17-22. PubMed ID: 18266224
    [Abstract] [Full Text] [Related]

  • 28. The Intergroup Rhabdomyosarcoma Study-II.
    Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J.
    Cancer; 1993 Mar 01; 71(5):1904-22. PubMed ID: 8448756
    [Abstract] [Full Text] [Related]

  • 29. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
    Spunt SL, Smith LM, Ruymann FB, Qualman SJ, Donaldson SS, Rodeberg DA, Anderson JR, Crist WM, Link MP.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6072-9. PubMed ID: 15447992
    [Abstract] [Full Text] [Related]

  • 30. The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.
    Spalding AC, Hawkins DS, Donaldson SS, Anderson JR, Lyden E, Laurie F, Wolden SL, Arndt CA, Michalski JM.
    Int J Radiat Oncol Biol Phys; 2013 Nov 01; 87(3):512-6. PubMed ID: 24074925
    [Abstract] [Full Text] [Related]

  • 31. Parameningeal rhabdomyosarcoma: outcomes and opportunities.
    Yang JC, Wexler LH, Meyers PA, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2013 Jan 01; 85(1):e61-6. PubMed ID: 23021437
    [Abstract] [Full Text] [Related]

  • 32. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study.
    Raney RB, Tefft M, Newton WA, Ragab AH, Lawrence W, Gehan EA, Maurer HM.
    Cancer; 1987 Jan 01; 59(1):147-55. PubMed ID: 3791141
    [Abstract] [Full Text] [Related]

  • 33. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee.
    Hays DM, Raney RB, Wharam MD, Wiener E, Lobe TE, Andrassy RJ, Lawrence W, Johnston J, Webber B, Maurer HM.
    J Pediatr Hematol Oncol; 1995 Feb 01; 17(1):46-52. PubMed ID: 7743237
    [Abstract] [Full Text] [Related]

  • 34. Early treatment failure in intermediate-risk rhabdomyosarcoma: results from IRS-IV and D9803--a report from the Children's Oncology Group.
    Minn AY, Lyden ER, Anderson JR, Million L, Arndt CA, Brown K, Hawkins DS, Donaldson SS.
    J Clin Oncol; 2010 Sep 20; 28(27):4228-32. PubMed ID: 20713850
    [Abstract] [Full Text] [Related]

  • 35. Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
    Doyen J, Jazmati D, Geismar D, Frisch S, Schleithoff SS, Vermeren X, Scheer M, Blase C, Tippelt S, Timmermann B.
    Int J Radiat Oncol Biol Phys; 2019 Dec 01; 105(5):1043-1054. PubMed ID: 31419513
    [Abstract] [Full Text] [Related]

  • 36. The Third Intergroup Rhabdomyosarcoma Study.
    Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R.
    J Clin Oncol; 1995 Mar 01; 13(3):610-30. PubMed ID: 7884423
    [Abstract] [Full Text] [Related]

  • 37. Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan AA, Parham DM, Cripe TP, Anderson JR, Meyer WH, Hawkins DS.
    J Clin Oncol; 2014 Nov 01; 32(31):3547-52. PubMed ID: 25267746
    [Abstract] [Full Text] [Related]

  • 38. Parameningeal rhabdomyosarcoma: results of an international workshop.
    Benk V, Rodary C, Donaldson SS, Flamant F, Maurer H, Treuner I, Carli M, Gehan E.
    Int J Radiat Oncol Biol Phys; 1996 Oct 01; 36(3):533-40. PubMed ID: 8948336
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.